• Most Popular
  • Most Shared

STOCKS NEWS EUROPE-Antisoma rises after cancer drug update

Fri May 15, 2009 4:56am EDT

Stocks

   

Shares in cancer specialist Antisoma (ASM.L) rise 3.3 percent to 31 pence after the company releases fresh data for its leukaemia drug AS1411 in the run up to the American Society of Clinical Oncology annual meeting at the end of May.

"We believe AS1411 continues to show encouraging safety and efficacy in relapsed/refractory acute myeloid leukaemia," say analysts at Piper Jaffray in a note to clients.

The broker has a "buy" recommendation on the stock and a target price of 81 pence.

Reuters messaging rm://ben.deighton.thomsonreuters.com@reuters.net


More from Reuters

U.S. Speaker of the House Nancy Pelosi (C) is surrounded by reporters as she walks towards the U.S. House of Representatives chamber to begin the vote on health care reform on Capitol Hill in Washington, March 21, 2010. REUTERS/Larry Downing

Democrats face dubious voters

Democrats in Congress who passed historic legislation to revamp the healthcare system face a new challenge: convincing voters it's a good deal.  Full Article | Video 

Healthcare reform
A soldier guards hundreds of bags of wheat seed in the isolated district of Nad Ali's district centre in the west of Helmand province, October 17, 2009

Dirty money and Afghan war

As the war in Afghanistan enters its ninth year, the U.S. has finally realized the best way to stop the conflict is to cut the flow of drug money, columnist Bernd Debusmann writes.   Commentary 

    Afghanistan
    An H1N1 flu vaccine inoculation is given at the Geisinger Medical Center in Danville, Pennsylvania October 28, 2009. REUTERS/Brad Bower

    A new stab at conquering pain

    Millions of people worldwide suffer chronic pain that can last weeks, months or years but relief may be on the way.  Full Article 

      Pharmaceuticals